The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXp Power Regulatory News (XPP)

Share Price Information for Xp Power (XPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,190.00
Bid: 1,172.00
Ask: 1,200.00
Change: 30.00 (2.59%)
Spread: 28.00 (2.389%)
Open: 1,174.00
High: 1,194.00
Low: 1,150.00
Prev. Close: 1,160.00
XPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and COVID-19 Impact

3 Apr 2020 07:00

XP POWER LTD - Trading Update and COVID-19 Impact

XP POWER LTD - Trading Update and COVID-19 Impact

PR Newswire

London, April 2

3 April 2020

XP Power Limited(“XP Power”, “the Group” or “the Company”)

Update on Q1 Trading and COVID-19 Impact

XP Power, one of the world's leading developers and manufacturers of critical power control components to the electronics industry, is today issuing a trading update for the first quarter ended 31 March 2020 and a further update on the impact of COVID-19.

COVID-19

We are continuing to monitor the global situation in respect of COVID-19 closely. The health, safety and well-being of our colleagues remains our first priority and we are providing our teams our full support, following all public health advice, and complying with all government directives.

All our manufacturing facilities are currently operational, and we are following all epidemic prevention and control measures in line with government guidelines. Manufacturing volumes in China have recovered strongly from the lows seen in February as production colleagues have returned to work, and production capacity is expected to return to normal levels during Q2. Our factories in Vietnam have continued to manufacture as normal with minimal impact from COVID-19. To date, component supply has been resilient, but we are monitoring supply chains closely.

Current trading

Trading in Q1 2020 has been in line with the Board’s expectations. Order intake continues to be strong with all sectors seeing order intake growth, with exceptional demand in Healthcare. Revenue growth has been encouraging, despite the extended shutdown of our manufacturing facility in China and the associated supply chain challenges we have experienced. The book to bill ratio, which tracks the relationship between orders received and completed sales, and which is an indicator of future revenue growth, was 1.49 for the first quarter (2019: 1.16 times) driven particularly by the demand from Healthcare customers.

£ MillionsQ1 2020Q1 2019ChangeChange in constant currency
Orders73.154.6+34%+33%
Revenue49.146.9+5%+4%
Book to Bill1.491.16+0.33

Financial position

Net debt at 31 March 2020 was £45.3 million compared to £41.3 million at 31 December 2019. The Group currently has immediately available committed liquidity of c.£50 million through bank facilities and cash balances.

The Group renewed its financing in November 2019 with a committed revolving credit facility of US$120m, with a US$60m accordion option. The facility is provided by HSBC UK Bank PLC, J.P. Morgan Securities PLC and DBS Bank Ltd with a four-year term up to November 2023. The Group retains strong liquidity and is trading very comfortably within its financial covenants. 

Cash management, dividend

In light of the increased level of uncertainty created by COVID-19, the Group is taking a prudent approach to its financial planning and is managing cash tightly. As such, the Board has decided to withdraw the resolution to approve the final dividend for 2019 of 36 pence per share at the forthcoming AGM. The total cash outflow from the 2019 final dividend was expected to be £6.9 million. The Group pays a quarterly dividend and understands the importance of dividends to shareholders. We intend to resume payments as soon as possible.

Outlook

While trading in the first quarter has been resilient, with some pull forward of demand and exceptional order strength in Healthcare, the global effort to combat COVID-19 creates a high level of uncertainty about the Group’s performance in the balance of the year. To date, order intake has remained robust and the Group has a substantial backlog to fulfil, with shipments weighted towards the second half. While we remain encouraged by the strength of our order book, the extent of disruption to the global economy from the impact of COVID-19 is currently impossible to predict, introducing a significant element of uncertainty into the outlook for 2020 as a whole.

Longer term, the Board believes XP Power to be very well positioned to grow ahead of its end markets supported by strong cash generation and a robust balance sheet.

Enquiries:

XP Power Duncan Penny, Chief Executive Officer +44 (0)118 976 5515Gavin Griggs, Chief Financial Officer +44 (0)118 976 5515

Citigate Dewe Rogerson Kevin Smith/Jos Bieneman +44 (0)20 7638 9571

Note to editors

XP Power designs and manufactures power controllers, the essential hardware component in every piece of electrical equipment that converts power from the electricity grid into the right form for equipment to function.

XP Power typically designs power control solutions into the end products of major blue-chip OEMs, with a focus on the Industrial Electronics (circa 45% of revenue), Healthcare (circa 23% of revenue), Semiconductor Equipment Manufacturing (circa 19% of revenue) and Technology (circa 13% of revenue) sectors. Once designed into a programme, XP Power has a revenue annuity over the life cycle of the customer’s product which is typically 5 to 7 years depending on the industry sector.

XP Power has invested in research and development and its own manufacturing facilities in China and Vietnam, to develop a range of tailored products based on its own intellectual property that provide its customers with significantly improved functionality and efficiency.

Headquartered in Singapore and listed on the Main Market of the London Stock Exchange since 2000, XP Power is a constituent of the FTSE 250 Index. XP Power serves a global blue-chip customer base from 29 locations in Europe, North America and Asia. 

For further information, please visit xppower.com

Date   Source Headline
25th Apr 202412:07 pmPRNResult of AGM
10th Apr 20247:00 amPRNQ1 Trading Update
21st Mar 202411:46 amPRNAnnual Financial Report
19th Mar 20242:32 pmPRNHolding(s) in Company
18th Mar 20244:47 pmPRNHolding(s) in Company
18th Mar 20244:01 pmPRNHolding(s) in Company
13th Mar 20247:01 amPRNGrant of LTIP, RSP and DBP awards
13th Mar 20247:00 amPRNDirector/PDMR Shareholding
5th Mar 20247:00 amPRNAnnual Financial Report
16th Feb 20247:00 amPRNTrading Update
1st Feb 20244:39 pmPRNHolding(s) in Company
30th Jan 202411:30 amPRNDirector Declaration: Additional Directorship
11th Jan 20247:00 amPRNTrading Update
1st Dec 20232:40 pmPRNTotal Voting Rights
10th Nov 20232:31 pmPRNHolding(s) in Company
7th Nov 20237:00 amRNSResults of Fundraise and PDMR Shareholdings
6th Nov 20234:39 pmRNSPrimaryBid Retail Offer
6th Nov 20234:35 pmRNSAnnouncement of Funding Plan and Placing
31st Oct 20232:29 pmPRNHolding(s) in Company
27th Oct 20237:00 amPRNTrading Update
9th Oct 20233:49 pmPRNHolding(s) in Company
6th Oct 20237:00 amPRNDividend Cancellation
4th Oct 20232:23 pmPRNHolding(s) in Company
2nd Oct 20237:00 amPRNTrading Update
18th Sep 20239:57 amPRNGrant of RSP and LTIP awards
15th Aug 20232:57 pmPRNHolding(s) in Company
1st Aug 20237:01 amPRNInterim Results
1st Aug 20237:00 amPRNAppointment of Chief Financial Officer
17th Jun 20224:41 pmRNSSecond Price Monitoring Extn
17th Jun 20224:36 pmRNSPrice Monitoring Extension
14th Apr 20224:35 pmRNSPrice Monitoring Extension
14th Apr 202212:20 pmPRNResult of AGM
14th Apr 20227:00 amPRNQ1 Trading Update
4th Apr 20224:16 pmPRNDirector/PDMR Shareholding
1st Apr 20227:00 amPRNTotal Voting Rights
24th Mar 20227:00 amRNSRe: Comet Legal Action
17th Mar 202212:57 pmPRNAnnual Financial Report
9th Mar 20229:44 amPRNGrant of LTIP, RSP and DBP awards
7th Mar 20227:00 amPRNBlocklisting - Interim Review
2nd Mar 20227:01 amEQSEdison Investment Research Limited: XP Power (XPP): Focused on efficiency and growth
1st Mar 20227:01 amPRNAnnual Results for the year ended 31 December 2021
1st Mar 20227:00 amPRNBoard Changes
31st Jan 20227:00 amPRNAcquisition
11th Jan 20227:00 amPRNTrading Update
22nd Nov 20217:00 amPRNHolding(s) in Company
11th Oct 20217:00 amPRNQ3 Trading Update
24th Aug 20219:49 amPRNDirector/PDMR Shareholding
2nd Aug 20217:00 amPRNHalf-year Report
22nd Jul 20218:36 amPRNDirector Declaration: Additional Directorship
14th May 20219:01 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.